GlassScriptPhysician profile
Ashley Weathers
NPI 1629734934
$512.27
in general payments reported to CMS, 2019-2025
16 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.50 · 2022: $93.40 · 2023: $18.49 · 2024: $53.94 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $94.14 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Astrazeneca Pharmaceuticals LP | $53.55 | 2024-2025 | Breztri, Airsupra |
| Lundbeck LLC | $44.88 | 2025 | Rexulti |
| Exact Sciences Corporation | $40.20 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $36.45 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $35.35 | 2021-2022 | |
| Lilly USA, LLC | $31.06 | 2025 | Zepbound, Mounjaro |
| Verona Pharma, INC. | $28.49 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $24.20 | 2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.05 | 2025 | Xifaxan |
| Abbott Laboratories | $22.09 | 2025 | Freestyle Libre |
| Alexion Pharmaceuticals, INC. | $18.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.12 | 2025 | Spravato |
| Novartis Pharmaceuticals Corporation | $16.83 | 2025 | |
| Amgen INC. | $13.79 | 2025 | Prolia, Evenity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Weathers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.